Literature DB >> 20098988

Moving from lymph node metastasis in gastric cancer to biological markers.

E Fatourou, D Ziogas, G Baltogiannis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20098988     DOI： 10.1007/s00268-009-0368-9

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  10 in total

1.  Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer.

Authors:  Dimitrios H Roukos
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

2.  Genome-wide association studies: how predictable is a person's cancer risk?

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Anticancer Ther       Date:  2009-04       Impact factor: 4.512

3.  Personalized cancer diagnostics and therapeutics.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2009-04       Impact factor: 5.225

4.  Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2009-04       Impact factor: 5.225

5.  Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-01-24       Impact factor: 5.344

6.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

7.  Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.

Authors:  D H Roukos; P Paraschou; M Lorenz
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

9.  Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.

Authors:  Naoto Fukuda; Yasuyuki Sugiyama; Akira Midorikawa; Hiroyuki Mushiake
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344
  10 in total
  2 in total

1.  Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.

Authors:  Biao Fan; Lian-Hai Zhang; Yong-Ning Jia; Xi-Yao Zhong; Yi-Qiang Liu; Xiao-Jing Cheng; Xiao-Hong Wang; Xiao-Fang Xing; Ying Hu; Ying-Ai Li; Hong Du; Wei Zhao; Zhao-Jian Niu; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

2.  Elementary screening of lymph node metastatic-related genes in gastric cancer based on the co-expression network of messenger RNA, microRNA and long non-coding RNA.

Authors:  Zhonghua Song; Wenhua Zhao; Danfeng Cao; Jinqing Zhang; Shouhua Chen
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.